10-Q: TerrAscend Corp. Reports Q2 2024 Results, Revenue Up 7% Year-Over-Year

Sentiment:

Quarterly Report


TerrAscend Corp. announced its second quarter 2024 financial results, showing a 7% increase in revenue compared to the same period last year, driven by growth in key markets.

Better than expectedThe company's net loss improved significantly, decreasing from $13.5 million in Q2 2023 to $6.2 million in Q2 2024.The company's working capital improved from negative $104.1 million at the end of 2023 to positive $27.4 million as of June 30, 2024.The company secured a new $140 million senior secured term loan, which will be used to retire existing debt and improve its financial position.

Summary

  • TerrAscend Corp. reported a net revenue of $77.5 million for the three months ended June 30, 2024, a 7% increase compared to $72.1 million in the same period of 2023.
  • The company's cost of sales increased to $39.8 million, up from $35.9 million year-over-year.
  • General and administrative expenses decreased to $24.1 million from $30.5 million year-over-year, primarily due to a bad debt recovery and insurance recovery.
  • The company experienced a net loss of $6.2 million for the quarter, compared to a net loss of $13.5 million in the second quarter of 2023.
  • For the six months ended June 30, 2024, net revenue was $158.2 million, a 12% increase from $141.5 million in the same period of 2023.
  • The company's net loss for the first six months of 2024 was $21.1 million, compared to a net loss of $36.2 million for the same period in 2023.
  • The company has refinanced its debt with a new $140 million senior secured term loan, addressing previous going concern issues.

Sentiment

Score: 7

Explanation: The document shows positive trends in revenue growth and reduced losses, along with successful debt refinancing. However, the company still faces challenges and risks, which temper the overall sentiment.

Positives

  • Revenue growth of 7% in Q2 2024 compared to Q2 2023, driven by adult-use sales in Maryland and acquisitions.
  • Significant reduction in net loss, from $13.5 million in Q2 2023 to $6.2 million in Q2 2024.
  • Decrease in general and administrative expenses by 21% year-over-year for the three months ended June 30, 2024.
  • Successful refinancing of debt with a new $140 million senior secured term loan, improving the company's financial stability.
  • Positive free cash flow of $22.1 million for the six months ended June 30, 2024.
  • The company's management has determined that substantial doubt no longer exists in the company's ability to continue as a going concern.

Negatives

  • The company still reported a net loss of $6.2 million for the quarter.
  • Cost of sales increased by 11% year-over-year for the three months ended June 30, 2024.
  • The company recorded an impairment loss of $2.4 million on property and equipment due to the wind-down of a California dispensary.
  • The company experienced a loss from revaluation of contingent consideration of $1.8 million for the three months ended June 30, 2024.

Risks

  • The cannabis industry is subject to changing regulations and federal laws in the U.S. that could impact operations.
  • The company faces competition in the cannabis market, which could affect its market share and profitability.
  • The company's future performance depends on its ability to manage its debt and access additional capital.
  • The company's tax positions are under review by the IRS, which could result in additional tax liabilities.
  • The company's operations are subject to risks related to product recalls and returns.

Future Outlook

The company expects to fund future capital requirements through cash from operations, market offerings, additional debt, sale of real property, sale-leaseback transactions, and exercise of options and warrants. The company anticipates continued growth in revenue and profitability due to the implementation of adult-use sales in Maryland and other strategic initiatives.

Management Comments

  • Management has determined that substantial doubt no longer exists in the company's ability to continue as a going concern.
  • Management believes that the company's new debt financing will improve its financial stability and allow it to pursue growth opportunities.

Industry Context

The cannabis industry is experiencing growth, particularly in states that have legalized adult-use sales. TerrAscend's performance reflects this trend, with revenue growth driven by the Maryland market. However, the company also faces challenges related to federal regulations and competition, which are common in the industry.

Comparison to Industry Standards

  • TerrAscend's revenue growth of 7% year-over-year for the three months ended June 30, 2024, is comparable to other multi-state operators (MSOs) in the cannabis industry, although some competitors may have experienced higher growth rates in specific markets.
  • The company's adjusted EBITDA margin of approximately 20% for the three months ended June 30, 2024, is within the range of other MSOs, but there is room for improvement as the company scales its operations.
  • The successful refinancing of debt is a positive development for TerrAscend, as many cannabis companies face challenges in accessing capital due to the federal illegality of cannabis.
  • Compared to companies like Curaleaf and Green Thumb Industries, TerrAscend is smaller in terms of market capitalization and revenue, but it is showing signs of improvement in its financial performance.

Legal Proceedings

  • A lawsuit filed by AEY Capital LLC against Pure X, LLC was settled and dismissed on June 28, 2024.

Related Party Transactions

  • Certain funds controlled by the company's Executive Chairman, Jason Wild, have invested approximately $7.5 million under the new FG Loan.

Stakeholder Impact

  • Shareholders will benefit from the improved financial performance and reduced risk of going concern.
  • Employees will benefit from the company's improved financial stability.
  • Customers will benefit from the company's continued investment in its operations and product offerings.
  • Creditors will benefit from the company's successful debt refinancing.

Next Steps

  • The company will continue to focus on growing its revenue and improving its profitability.
  • The company will use the proceeds from the new debt financing to retire existing debt and invest in growth opportunities.
  • The company will continue to monitor and manage its tax positions and legal proceedings.

Key Dates

DateDescription
March 7, 2017TerrAscend Corp. was incorporated under the Business Corporations Act (Ontario).
May 3, 2017The common shares commenced trading on the Canadian Securities Exchange (CSE).
October 22, 2018The common shares commenced trading on OTCQX under the ticker symbol 'TRSSF'.
December 18, 2020WDB Holding PA, a subsidiary of TerrAscend, entered into a senior secured term loan with a syndicate of lenders in the amount of $120,000 (Ilera Term Loan).
March 10, 2022The company completed the Gage Acquisition.
October 11, 2022Subsidiaries of TerrAscend entered into a loan agreement with Pelorus Fund REIT, LLC for a senior secured term loan.
April 18, 2023The company and TerrAscend entered into a protection agreement.
April 20, 2023TerrAscend issued Class A shares to an investor.
June 26, 2023The company closed on a $25,000 commercial loan with Stearns Bank.
July 4, 2023The common shares commenced trading on the TSX under the ticker symbol 'TSND'.
July 6, 2023The common shares ticker symbol on OTCQX was changed to 'TSNDF'.
August 9, 2023AEY Capital LLC filed a lawsuit against Pure X, LLC.
January 2, 2024The company made a prepayment of $4,800 of the Ilera Term Loan.
January 19, 2024The company reduced its non-controlling interest through the acquisition of the remaining 50.1% equity in both State Flower and three Apothecarium dispensaries in California.
April 30, 2024The company made a prepayment of $3,200 of the Ilera Term Loan.
June 28, 2024The lawsuit between AEY Capital LLC and Pure X, LLC was settled and dismissed.
June 30, 2024End of the reporting period for the quarterly report.
July 19, 2024The company made a prepayment of the Chicago Atlantic Term Loan of $1,500.
August 1, 2024The company entered into a four-year $140,000 senior secured term loan with FG Agency Lending LLC.
August 8, 2024Date of the quarterly report filing.
September 30, 2024Expected date for the delayed draw of $26,000 from the FG Loan.

Keywords

cannabis, financial results, revenue, net loss, debt refinancing, EBITDA, operating expenses, acquisitions, Maryland, New Jersey, Pennsylvania, Michigan, California

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.